MediWound (MDWD) vs Trulieve Cannabis Subordinate Voting Shares (TRLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Trulieve Cannabis Subordinate Voting Shares (TRLV) has outperformed MediWound (MDWD) over the past year, gaining 18.0% versus a loss of 29.5%. Over five years, MDWD leads with a -48.0% price change compared with -60.5% for TRLV. Trulieve Cannabis Subordinate Voting Shares is the larger company by market cap ($2.00 billion vs $160.3 million), about 12.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDWD | TRLV |
|---|---|---|
| Share price | $12.42 | $10.37 |
| Market cap | $160.35M | $2.00B |
| 1-day change | -3.35% | -3.80% |
| YTD return | -32.72% | +19.33% |
| 1-year return | -29.53% | +17.97% |
| 5-year return | -47.97% | -60.45% |
| Forward P/E | — | 18.63 |
| EPS (TTM) | $-2.17 | $-2.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.03 | $13.28 |
| 52-week low | $12.42 | $4.62 |
| Distance from 52-week high | -37.99% | -21.91% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +146.94% | +75.31% |
| Average volume | 84.67K | 1.61M |
| Shares outstanding | 12.91M | 170.16M |
| Employees | 121 | 5,000 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Trulieve Cannabis Subordinate Voting Shares is about 12.5 times larger than MediWound by market value ($2.00B vs $160.35M).
- TRLV has outperformed MDWD by 47.5 percentage points over the past year.
About MediWound
MDWD stock →MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
Health Care · Medicinal Chemicals and Botanical Products · 121 employees
About Trulieve Cannabis Subordinate Voting Shares
TRLV stock →Trulieve Cannabis Corp. operates as a cannabis retailer in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 5,000 employees
MDWD vs TRLV FAQ
Which is bigger, MediWound or Trulieve Cannabis Subordinate Voting Shares?
Trulieve Cannabis Subordinate Voting Shares (TRLV) is larger, with a market capitalization of $2.00B compared with $160.35M for MediWound (MDWD).
Which stock has performed better over the past year, MDWD or TRLV?
TRLV returned +17.97% over the past 12 months, compared with -29.53% for MDWD (price return, excluding dividends). Past performance does not predict future results.
Are MediWound and Trulieve Cannabis Subordinate Voting Shares in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.